Targeting cytosolic proliferating cell nuclear antigen in neutrophil-dominated inflammation

Frontiers in Immunology

Volumn 3, Issue OCT, 2012, Pages

  De Chiara, Alessia ^a,b,c   Pederzoli Ribeil, Magali ^a,b,c   Burgel, Pierre Régis ^b,d   Danel, Claire ^b,e   Witko Sarsat, Véronique ^a,b,c  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CNRS   (France)

^d Cochin Hospital ^*  (France)

^e BICHAT HOSPITAL   (France)

Author keywords

Apoptosis; Cystic fibrosis; Inflammation; Neutrophil; Pcna

Indexed keywords

EID: 84874284447     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00311     Document Type: Article

References (66)

1. Abdgawad, M., Pettersson, A., Gunnars-son, L., Bengtsson, A. A., Geborek, P., Nilsson, L., et al. (2012). Decreased neutrophil apoptosis in quiescent ANCA-associated systemic vasculi-tis. PLoS ONE 7, e32439. doi: 10.1371/journal.pone.0032439
2. Adib-Conquy, M., Pedron, T., Petit-Bertron, A. F., Tabary, O., Corvol, H., Jacquot, J., et al. (2008). Neu-trophils in cystic fibrosis display a distinct gene expression pattern. Mol. Med. 14, 36-44.
3. Ariel, A., and Serhan, C. N. (2012). New lives given by cell death: macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation. Front. Immunol. 3, 4. doi: 10.3389/fimmu.2012.00004
4. Bals, R., Weiner, D. J., and Wilson, J. M. (1999). The innate immune system in cystic fibrosis lung disease. J. Clin. Invest. 103, 303-307.
5. Biggs, J. R., and Kraft, A. S. (1995). Inhibitors of cyclin-dependent kinase and cancer. J. Mol. Med. (Berl.) 73, 509-514.
6. Bonfield, T. L., Hodges, C. A., Cotton, C. U., and Drumm, M. L. (2012) Absence of the cystic fibro-sis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection. J. Leukoc. Biol. (in press).
7. Bouayad, D., Pederzoli-Ribeil, M., Mocek, J., Candalh, C., Arlet, J. B., Hermine, O., et al. (2012). Nuclear-to-cytoplasmic relocalization of the proliferating cell nuclear antigen (PCNA) during granulocytic differentiation involves a chromosome region maintenance 1 (CRM1)-dependent export and is a prerequisite for PCNA anti-apoptotic activity in mature neutrophils. J. Biol. Chem. (in press).
8. Burgel, P. R., Montani, D., Danel, C., Dusser, D. J., and Nadel, J. A. (2007). A morphometric study of mucins and small airway plugging in cystic fibrosis. Thorax 62, 153-161.
9. Burgel, P. R., and Nadel, J. A. (2008). Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur. Respir. J. 32, 1068-1081.
10. Cantin, A. (1995). Cystic fibrosis lung inflammation: early, sustained, and severe. Am. J. Respir. Crit. Care Med. 151, 939-941.
11. Coldren, C. D., Nick, J. A., Poch, K. R., Woolum, M. D., Fouty, B. W., O'Brien, J. M., et al. (2006). Functional and genomic changes induced by alveolar transmigration in human neutrophils. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L1267- L1276.
12. Danel, C., Erzurum, S. C., McEl-vaney, N. G., and Crystal, R. G. (1996). Quantitative assessment of the epithelial and inflammatory cell populations in large airways of normals and individuals with cystic fibrosis. Am. J. Respir. Crit. Care Med. 153, 362-368.
13. Dibbert, B., Weber, M., Nikolaizik, W. H., Vogt, P., Schoni, M. H., Blaser, K., et al. (1999). Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. Proc. Natl. Acad. Sci. U.S.A. 96, 13330- 13335.
14. Downey, D. G., Bell, S. C., and Elborn, J. S. (2009). Neutrophils in cystic fibrosis. Thorax 64, 81-88.
15. Drewniak, A., van Raam, B. J., Geissler, J., Tool, A. T., Mook, O. R., van den Berg, T. K., etal. (2009). Changes in gene expression of granulocytes during in vivo granulocyte colony-stimulating fac-tor/dexamethasone mobilization for transfusion purposes. Blood 113, 5979-5998.
16. Duffin, R., Leitch, A. E., Fox, S., Haslett, C., and Rossi, A. G. (2010). Targeting granulocyte apoptosis: mechanisms, models, and therapies. Immunol. Rev. 236, 28-40.
17. Esmann, L., Idel, C., Sarkar, A., Hell-berg, L., Behnen, M., Möller, S., et al. (2010). Phagocytosis of apop-totic cells by neutrophil granulo-cytes: diminished proinflammatory neutrophil functions in the presence of apoptotic cells. J. Immunol. 184, 391-400.
18. Fox, S., Leitch, A. E., Duffin, R., Haslett, C., and Rossi, A. G. (2010). Neu-trophil apoptosis: relevance to the innate immune response and inflammatory disease. J. Innate Immun. 2, 216-227.
19. Geering, B., and Simon, H. U. (2011). Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ. 18, 1457-1469.
20. Goubin, F., and Ducommun, B. (1995). Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene 10, 2281-2287.
21. Grogan, A., Reeves, E., Keep, N., Wientjes, F., Totty, N. F., Burlingame, A. L., etal. (1997). Cytosolic phox proteins interact with and regulate the assembly of coronin in neutrophils. J. Cell Sci. 110, 3071-3081.
22. Hayes, E., Pohl, K., McElvaney, N. G., and Reeves, E. P. (2011). The cystic fibrosis neutrophil: a specialized yet potentially defective cell. Arch. Immunol. Ther. Exp. 59, 97-112.
23. Jonsson, Z. O., Podust, V. N., Podust, L. M., and Hubscher, U. (1995). Tyro-sine 114 is essential for the trimeric structure and the functional activities of human proliferating cell nuclear antigen. EMBO J. 14, 5745-5751.
24. Kelman, Z. (1997). PCNA: structure, functions and interactions. Oncogene 14, 629-640.
25. Kennedy, A. D., and DeLeo, F. R. (2009). Neutrophil apoptosis and the resolution of infection. Immunol. Res. 43, 25-61.
26. Kepp, O., Galluzzi, L., Lipinski, M., Yuan, J., and Kroemer, G. (2011). Cell death assays for drug discovery. Nat. Rev. Drug Discov. 10, 221-237.
27. Klausen, P., Bjerregaard, M. D., Bor-regaard, N., and Cowland, J. B. (2004). End-stage differentiation of neutrophil granulocytes in vivo is accompanied by up-regulation of p27kip1 and down-regulation of CDK2, CDK4, and CDK6. J. Leukoc. Biol. 75, 569-578.
28. Kobayashi, S. D., Voyich, J. M., Buhl, C. L., Stahl, R. M., and DeLeo, F. R. (2002). Global changes in gene expression by human poly-morphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression. Proc. Natl. Acad. Sci. U.S.A. 99, 6901-6906.
29. Krishna, T. S., Kong, X. P., Gary, S., Burgers, P. M., and Kuriyan, J. (1994). Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA. Cell 79, 1233-1243.
30. Leitch, A. E., Lucas, C. D., Mar-wick, J. A., Duffin, R., Haslett, C., and Rossi, A. G. (2012). Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation. Cell Death Differ. doi: 10.1038/cdd.2012.80. [Epub ahead of print].
31. Maga, G., and Hubscher, U. (2003). Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J. Cell Sci. 116, 3051-3060.
32. Mahler, M., Miyachi, K., Peebles, C., and Fritzler, M. J. (2012). The clinical significance of autoantibodies to the proliferating cell nuclear antigen (PCNA). Autoimmun. Rev. 11, 771-775.
33. Malumbres, M., Harlow, E., Hunt, T., Hunter, T., Lahti, J. M., Manning, G., et al. (2009). Cyclin-dependent kinases: a family portrait. Nat. Cell Biol. 11, 1275-1276.
34. Mantovani, A., Cassatella, M. A., Costantini, C., and Jaillon, S. (2011). Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11, 519-531.
35. McKeon, D. J., Condliffe, A. M., Cowburn, A. S., Cadwallader, K. C., Farahi, N., Bilton, D., etal. (2008). Prolonged survival of neu-trophils from patients with Delta F508 CFTR mutations. Thorax 63, 660-661.
36. Milot, E., and Filep, J.G.(2011). Regulation of neutrophil survival/apoptosis by Mcl-1. Sci. World J. 11, 1948-1962.
37. Moldovan, G. L., Pfander, B., and Jentsch, S. (2007). PCNA, the maestro of the replication fork. Cell 129, 665-679.
38. Moriceau, S., Kantari, C., Mocek, J., Davezac, N., Gabillet, J., Guerrera, I. C., et al. (2009). Coronin-1 is associated with neutrophil survival and is cleaved during apoptosis: potential implication in neutrophils from cystic fibrosis patients. J. Immunol. 182, 7254-7263.
39. Moriceau, S., Lenoir, G., and Witko-Sarsat, V. (2010). In cystic fibro-sis homozygotes and heterozygotes, neutrophil apoptosis is delayed and modulated by diamide or roscovi-tine: evidence for an innate neu-trophil disturbance. J. Innate Immun. 2, 260-266.
40. Moulding, D. A., Akgul, C., Derouet, M., White, M. R., and Edwards, S. W. (2001). BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. J. Leukoc. Biol. 70, 783-792.
41. Narasimhan, M., and Cohen, R. (2011). New and investigational treatments in cystic fibrosis. Ther. Adv. Respir. Dis. 5, 275-282.
42. Naryzhny, S. N., and Lee, H. (2004). The post-translational modifications of proliferating cell nuclear antigen: acetylation, not phosphoryla-tion, plays an important role in the regulation of its function. J. Biol. Chem. 279, 20194-20199.
43. Naryzhny, S. N., and Lee, H. (2010). Proliferating cell nuclear antigen in the cytoplasm interacts with components of glycolysis and cancer. FEBS Lett. 584, 4292-4298.
44. Nathan, C. (2006). Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6, 173-182.
45. Paidassi, H., Tacnet-Delorme, P., Arlaud, G. J., and Frachet, P. (2009). How phagocytes track down and respond to apoptotic cells. Crit. Rev. Immunol. 29, 111-130.
46. Pier, G. B. (2012). The challenges and promises of new therapies for cystic fibrosis. J. Exp. Med. 209, 1235-1239.
47. Prosperi, E. (2006). The fellowship of the rings: distinct pools of proliferating cell nuclear antigen trimer at work. FASEB J. 20, 833-837.
48. Rossi, A. G., Sawatzky, D. A., Walker, A., Ward, C., Sheldrake, T. A., Riley, N. A., et al. (2006). Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat. Med. 12, 1056-1064.
49. Stoimenov, I., and Helleday, T. (2009). PCNA on the crossroad of cancer. Biochem. Soc. Trans. 37, 605-613.
50. Theilgaard-Monch, K., Jacobsen, L. C., Borup, R., Rasmussen, T., Bjerre-gaard, M. D., Nielsen, F. C., et al. (2005). The transcriptional program of terminal granulocytic differentiation. Blood 105, 1785-1796.
51. Thomas, L. W., Lam, C., and Edwards, S. W. (2010). Mcl-1; the molecular regulation of protein function. FEBS Lett. 584, 2981-2989.
52. Tirouvanziam, R., Gernez, Y., Conrad, C. K., Moss, R. B., Schrijver, I., Dunn, C E., et al. (2008). Profound func tional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc. Natl. Acad. Sci. U.S.A. 105, 4335-4339.
53. Turner, J. G., Dawson, J., and Sullivan, D M. (2012). Nuclear export of pro teins and drug resistance in cancer. Biochem. Pharmacol. 83, 1021-1032.
54. Vandivier, R. W., Fadok, V. A., Hoffmann, P. R., Bratton, D. L., Pen-vari, C., Brown, K. K., et al. (2002). Elastase-mediated phosphatidylser-ine receptor cleavage impairs apop-totic cell clearance in cystic fibrosis and bronchiectasis. J. Clin. Invest. 109, 661-670.
55. Waga, S., Hannon, G. J., Beach, D., and Stillman, B. (1994). The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578.
56. Warbrick, E. (2000). The puzzle of PCNA's many partners. Bioessays 22, 997-1006.
57. Witko-Sarsat, V., Allen, R. C., Paulais, M., Nguyen, A. T., Bessou, G., Lenoir, G., et al. (1996). Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibro-sis homozygotes and heterozygotes, and its correction by amiloride. J. Immunol. 157, 2728-2735.
58. Witko-Sarsat, V., Halbwachs-Mecarelli, L., Sermet-Gaudelus, I., Bessou, G., Lenoir, G., Allen, R. C., et al. (1999). Priming of blood neutrophils in children with cystic fibrosis: correlation between functional and phenotypic expression of opsonin receptors before and after platelet-activating factor priming. J. Infect. Dis. 179, 151-162.
59. Witko-Sarsat, V., Mocek, J., Bouayad, D., Tamassia, N., Ribeil, J. A., Can-dalh, C., et al. (2010). Proliferating cell nuclear antigen acts as a cyto-plasmic platform controlling human neutrophil survival. J. Exp. Med. 207, 2631-2645.
60. Witko-Sarsat, V., Pederzoli-Ribeil, M., Hirsch, E., Sozzani, S., and Cas-satella, M. A. (2011). Regulating neutrophil apoptosis: new players enter the game. Trends Immunol. 32, 117-124.
61. Witko-Sarsat, V., Rieu, P., Descamps-Latscha, B., Lesavre, P., and Halbwachs-Mecarelli, L. (2000). Neutrophils: molecules, functions and pathophysiological aspects. Lab. Invest. 80, 617-653.
62. Wright, A. K., Rao, S., Range, S., Eder, C., Hofer, T. P., Frankenberger, M., et al. (2009). Pivotal Advance: expansion of small sputum macrophages in CF: failure to express MARCO and mannose receptors. J. Leukoc. Biol. 86, 479-489.
63. Wright, H. L., Moots, R. J., Bucknall, R. C., and Edwards, S. W. (2010). Neutrophil function in inflammation and inflammatory diseases. Rheumatology 49, 1618-1631.
64. Xiong, Y., Zhang, H., and Beach, D. (1992). D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71, 505-514.
65. Yaroslavskiy, B., Watkins, S., Donnen-berg, A. D., Patton, T. J., and Stein-man, R. A. (1999). Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells. Blood 93, 2907-2917.
66. Zhu, D., Hattori, H., Jo, H., Jia, Y., Subramanian, K. K., Loison, F., et al. (2006). Deactivation of phosphatidylinositol 3,4,5-trisphosphate/Akt signaling mediates neutrophil spontaneous death. Proc. Natl. Acad. Sci. U.S.A. 103, 14836-14841.